Heart disease and urban heat exposure in South Asian urban populations: Socioeconomic disparities and health policy prospective

Heart Lung. 2026 Jun 4;79:102861. doi: 10.1016/j.hrtlng.2026.102861. Online ahead of print.ABSTRACTBACKGROUND: In South Asia, climate change caused rising urban heat, and rapid urbanisation has become a major public health concern, particularly for cardiovascular health. However, socioeconomic facto

M Muhammad Muneeb Hassan

Echocardiography-based intelligent diagnosis and risk stratification management for tetralogy of Fallot

EBioMedicine. 2026 Jun 4;129:106292. doi: 10.1016/j.ebiom.2026.106292. Online ahead of print.ABSTRACTBACKGROUND: Early and accurate detection of Tetralogy of Fallot (TOF), along with proper risk stratification management, is critical for improving patient survival and prognosis. We developed an end-

Q Qiang Gao

Associations of Fatherhood and Race With Cardiovascular Health Among Men: Findings From the Coronary Artery Risk Development in Young Adults (CARDIA) Study, 1985-2022, United States

Am J Public Health. 2026 Jun 4:e1-e10. doi: 10.2105/AJPH.2026.308439. Online ahead of print.ABSTRACTObjectives. To estimate associations of fatherhood with cardiovascular health (CVH), incident cardiovascular disease (CVD), and all-cause mortality. Methods. The Coronary Artery Risk Development in Yo

J John James Parker

Decades of Research in the Chronic Disease Self-Management Program: A Systematic Review and Meta-Analysis of Long-Term Health Outcomes Across Countries

Am J Public Health. 2026 Jun 4:e1-e12. doi: 10.2105/AJPH.2025.308381. Online ahead of print.ABSTRACTBackground. The evidence-based Chronic Disease Self-Management Program (CDSMP) has been widely implemented and adapted globally for decades, yet no comprehensive analysis of its outcomes after 2009 ha

R Robert Olszewski

Target Trial Emulation of Alcohol Intake Interventions in Young Adults and Risk of CVD over 30 years: Data from the CARDIA study

Eur J Prev Cardiol. 2026 Jun 4:zwag302. doi: 10.1093/eurjpc/zwag302. Online ahead of print.ABSTRACTAIM: This study uses a target trial emulation framework to estimate how different hypothetical sustained alcohol intake patterns affect 30-year cardiovascular disease risk in young adults.METHODS: This

J Jiarui Li

Assessing Staff Knowledge of Nutritional Management in Patients with Chronic Kidney Disease: A Quality Improvement Project

Nephrol Nurs J. 2026 Mar-Apr;53(2):123-132.ABSTRACTChronic kidney disease (CKD) is a chronic illness linked to major metabolic abnormalities, including high levels of potassium and phosphorus. These abnormalities can lead to serious complications, such as bone and cardiovascular diseases. There are

N Nivia Talley

From sleep disorders to social determinants - risk predictors for cardiovascular diseases beyond low density lipoprotein cholesterol

No abstractCurr Opin Cardiol. 2026 Jul 1;41(4):267. doi: 10.1097/HCO.0000000000001314. Epub 2026 Jun 4.NO ABSTRACTPMID:42241575 | DOI:10.1097/HCO.0000000000001314

D Debabrata Mukherjee

CETP Inhibitors: Back With a New Target

Circ Res. 2026 Jun 5;138(12):e327271. doi: 10.1161/CIRCRESAHA.125.327271. Epub 2026 Jun 4.ABSTRACTCETP (cholesteryl ester transfer protein) plays an important role in lipid metabolism, facilitating the exchange of esterified cholesterol for triglycerides between lipoproteins. Genetic and cohort stud

S Stephen J Nicholls

New and Emerging Therapeutic Targets for ApoB-Containing Particles Lowering

Circ Res. 2026 Jun 5;138(12):e327270. doi: 10.1161/CIRCRESAHA.126.327270. Epub 2026 Jun 4.ABSTRACTApoB is the structural protein of all atherogenic lipoproteins, including VLDLs (very-low-density lipoproteins), IDLs (intermediate-density lipoproteins), LDLs (low-density lipoproteins), chylomicron re

D Daniel Gaudet

Adipose Tissue Plasticity, Lipoprotein Metabolism, and Cardiovascular Risk: The Emerging Role of the GLP-1 Axis

Circ Res. 2026 Jun 5;138(12):e328680. doi: 10.1161/CIRCRESAHA.126.328680. Epub 2026 Jun 4.ABSTRACTObesity and its cardiometabolic sequelae remain a public health challenge. GLP-1R (glucagon-like peptide-1 receptor) agonists have emerged as a transformative therapy to combat obesity. Although weight

G Giuliana G Repetti

Cardiac Lipid Metabolism: Cells, Metabolites, and Rhythms

Circ Res. 2026 Jun 5;138(12):e327471. doi: 10.1161/CIRCRESAHA.126.327471. Epub 2026 Jun 4.ABSTRACTAlthough studied for decades, metabolic therapies that target cardiac lipid metabolism are underdeveloped, and most approaches have thus far failed as a heart failure treatment. In contrast, new therapi

I Ira J Goldberg

Kidney-Vascular Metabolic Crosstalk: Altered Lipoproteins in CKD

Circ Res. 2026 Jun 5;138(12):e327361. doi: 10.1161/CIRCRESAHA.126.327361. Epub 2026 Jun 4.ABSTRACTCardiovascular disease and chronic kidney disease are highly interconnected, with declining kidney function markedly increasing cardiovascular risk. Chronic kidney disease profoundly disrupts lipoprotei

K Keith L Saum

Lipoproteins in Cardiovascular Disease: Building on Successes to Meet Future Challenges

No abstractCirc Res. 2026 Jun 5;138(12):e328994. doi: 10.1161/CIRCRESAHA.126.328994. Epub 2026 Jun 4.NO ABSTRACTPMID:42241513 | DOI:10.1161/CIRCRESAHA.126.328994

K Karin E Bornfeldt

Hepatic Lipoprotein Production, Cardiometabolic Phenotypes, and Subtypes of Steatotic Liver Disease

Circ Res. 2026 Jun 5;138(12):e327269. doi: 10.1161/CIRCRESAHA.126.327269. Epub 2026 Jun 4.ABSTRACTMetabolic dysfunction-associated steatotic liver disease (MASLD) impacts more than a third of adults worldwide. The burgeoning epidemic of MASLD has led to increases in atherosclerotic cardiovascular di

N Nicholas O Davidson

Triglyceride-Rich Lipoprotein Metabolism and Cardiovascular Risk in Diabetes: Bedside to Bench to Bedside

Circ Res. 2026 Jun 5;138(12):e327267. doi: 10.1161/CIRCRESAHA.125.327267. Epub 2026 Jun 4.ABSTRACTType 1 diabetes and type 2 diabetes are associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD), manifested as myocardial infarction, ischemic stroke, and peripheral artery d

H Henry N Ginsberg

Century of Progress on the Structure of APOB-100 in Atherogenic Lipoproteins

Circ Res. 2026 Jun 5;138(12):e328575. doi: 10.1161/CIRCRESAHA.126.328575. Epub 2026 Jun 4.ABSTRACTAPOB-100 (apolipoprotein B100) is the obligate structural protein of very low-density lipoprotein (VLDL), intermediate density lipoprotein, and low-density lipoprotein (LDL), with each atherogenic parti

B Bethany Coleman

HDL Are Host Defense Lipoproteins

Circ Res. 2026 Jun 5;138(12):e327426. doi: 10.1161/CIRCRESAHA.126.327426. Epub 2026 Jun 4.ABSTRACTHundreds of proteins and lipid species give HDLs (high-density lipoproteins) their polydispersity and multifunctionality. Studies have shown that plasma levels of HDL cholesterol (HDL-C) and apo AI (apo

A Arnold von Eckardstein

Antibody E06 and the Role of Oxidized Phospholipids in Atherogenesis and Inflammation

Circ Res. 2026 Jun 5;138(12):e327359. doi: 10.1161/CIRCRESAHA.126.327359. Epub 2026 Jun 4.ABSTRACTOxidized phospholipids (OxPL) are generated at sites of oxidative stress and tissue injury, where they function as prototypic danger-associated molecular patterns that trigger inflammation, cell death,

J Joseph L Witztum

Psychic Dynamics in an Adult With Acute Coronary Syndrome: A Case Study

Psychoanal Rev. 2026 Jun;113(2):103-129. doi: 10.1521/prev.2026.113.2.103.ABSTRACTThis case study describes and analyzes the psychodynamic experiences of an adult hospitalized after an acute cardiac event. Pierre, a 46-year-old Brazilian man with a high level of education, sought medical care for ch

A Aline Cristina Antonechen

Eosinophil count trajectories are associated with the prognosis of acute myocardial infarction patients: Insights from ICU data analysis

PLoS One. 2026 Jun 4;21(6):e0349827. doi: 10.1371/journal.pone.0349827. eCollection 2026.ABSTRACTOBJECTIVE: Previous clinical studies have demonstrated conflicting evidence regarding the relationship between eosinophil (EOS) count and adverse outcomes in acute myocardial infarction (AMI). This study

W Wen-Chao Zhang

Perceptions, attitudes, behaviours and barriers towards obesity among people with obesity and health care professionals in Indonesia: An exploratory online survey

PLoS One. 2026 Jun 4;21(6):e0350857. doi: 10.1371/journal.pone.0350857. eCollection 2026.ABSTRACTBACKGROUND: The Awareness, Care, and Treatment In Obesity maNagement Asia Pacific (ACTION APAC) online survey identified perceptions, attitudes, and barriers to effective obesity care among People with O

S Sidartawan Soegondo

Renal Replacement Therapy in CKM: Challenges for Dialytic Therapies and Kidney Transplantation

Cardiorenal Med. 2026 Jun 4:1-12. doi: 10.1159/000552830. Online ahead of print.ABSTRACTCardiovascular-kidney-metabolic (CKM) syndrome integrates the strong interrelationship among cardiovascular disease (CVD), chronic kidney disease (CKD), and metabolic risk factors such as obesity and diabetes. Re

M Mahtab Mashayekhi

Amniotic Fluid Embolism: A Silent Threat to Maternal Life- An Up-to-Date Comprehensive Review of the Pathophysiology, Diagnosis, and Outcome

Obstet Gynecol Surv. 2026 Jun 1;81(6):304-314. doi: 10.1097/OGX.0000000000001554. Epub 2026 Jun 4.ABSTRACTIMPORTANCE: Amniotic fluid embolism is a serious complication of pregnancy where fetal cells, amniotic fluid, and debris enter the maternal circulation, leading to cardiovascular collapse, respi

O Oluwateniayo O Okpaise

Neutrophil Percentage-to-Albumin Ratio as a Novel Biomarker in Patients with Group 1 Pulmonary Arterial Hypertension

Niger J Clin Pract. 2026 May 1;29(5):559-566. doi: 10.4103/njcp.njcp_816_25. Epub 2026 May 29.ABSTRACTBACKGROUND: Pulmonary arterial hypertension (PAH) is a progressive and life-threatening disease characterized by increased pulmonary vascular resistance, right ventricular failure, and systemic infl

I I Aktaş